You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中国再生医学(08158.HK)拟与金新合作开发医疗产业园
格隆汇 03-22 20:51

格隆汇 3 月 22日丨中国再生医学(08158.HK)宣布,于2021年3月22日,公司与金新控股集团("金新")订立不具法律约束力的意向备忘录,内容有关可能于中国共同发展医疗产业园。

金新为于中国发展医疗产业园,已成立常州中再生健康产业发展有限公司("目标公司")。根据意向备忘录,已拟定(i)公司将有权(但并无责任)投资目标公司的总计合共最多50%股权;及(ii)集团将负责(其中包括)设计建议、品牌打造及客户引入,而金新将负责(其中包括)产业园的土地招标、建设及营运。

据悉,金新为于中国注册成立的有限公司,主要从事房地产发展,涵盖保健及接待等多个行业。目标公司为于中国注册成立的有限责任公司,由金新全资拥有。目标公司的业务范畴包括房地产开发经营、工程建设、健康谘询服务、住房及非居住房租赁及物业管理。

公告称,集团主要从事组织工程及再生医学产品的研发、生产及销售,其业务范围横跨多个界别,包括组织工程、化妆品、细胞存储、制备及治疗及医院管理。集团的业务策略为与中国公司合作,以补足集团的资源及优势,提高公司在中国的服务水平。

董事认为,一旦落实,与金新合作开发医疗产业园将有助集团在中国提高服务水平及拓展渠道,而金新所拥有的房地产资源及行业经验,将于该合作中战略补足集团在医院管理方面的资源及专业知识。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account